Get the app!
Back to Trades
Sell4

REPLIGEN CORP

RGEN

Total Value
$4.9M
Net $3.5M sold
Sales
$3.5M
6 transactions

Company Information

Company Name
REPLIGEN CORP
Ticker Symbol
RGEN
CIK
0000730272

Insider Information

Role
Insider
Location
WALTHAM, MA

Filing Details

Filing Date
Sep 11, 2025
Transaction Date
Sep 10, 2025
Accession Number
0001193125-25-201224
Form Type
4
Net Trading Amount
-$3.5M

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Sep 10, 2025Common Stock20,000$33.87Exercise$677.4K
Sep 10, 2025Common Stock96$116.34Sale$11.2K
Sep 10, 2025Common Stock1,108$118.32Sale$131.1K
Sep 10, 2025Common Stock3,262$119.64Sale$390.3K
Sep 10, 2025Common Stock14,882$120.19Sale$1.8M
Sep 10, 2025Common Stock7,584$121.42Sale$920.8K
Sep 10, 2025Common Stock2,179$122.23Sale$266.3K

Derivative Transactions

DateSecuritySharesExercise PriceTypeValue
Sep 10, 2025Derivative20,000$33.87Exercise$677.4K

Footnotes

  1. (F1)Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2024.
  2. (F2)$118.32 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.80 to $118.76, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  3. (F3)$119.64 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.83 to $119.83, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  4. (F4)$120.19 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.85 to $120.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  5. (F5)$121.42 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.86 to $121.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  6. (F6)$122.23 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.92 to $122.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  7. (F7)207,344 of the shares underlying this option have vested. The remaining shares vest as follows: 28,777 shares on March 1, 2026, and 28,778 shares on March 1, 2027.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.